about
Treatment of Cushing disease: overview and recent findingsDissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effectsBone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms.Energy restriction reduces fractional calcium absorption in mature obese and lean rats.Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways.Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy.Treatment of glucocorticoid-induced osteoporsisThe relationship between alcohol consumption and cortisol secretion in an aging cohort.Bone geometry profiles in women with and without SLE.Phenotype-Genotype Association Analysis of ACTH-Secreting Pituitary Adenoma and Its Molecular Link to Patient Osteoporosis.Glucocorticoid-induced osteoporosis and parathyroid hormone.Systemic medication and the inflammatory cascade.Definition of the transcription factor TdIF1 consensus-binding sequence through genomewide mapping of its binding sites.The biochemical signatures of stress: A preliminary analysis of osteocalcin concentrations and macroscopic skeletal changes associated with stress in the 13th - 17th centuries black friars population.Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome.Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.Low Doses of Simvastatin Potentiate the Effect of Sodium Alendronate in Inhibiting Bone Resorption and Restore Microstructural and Mechanical Bone Properties in Glucocorticoid-Induced Osteoporosis.Glucocorticoid therapy as a significant risk factor for osteoporosis and fractures in an Italian postmenopausal population.Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale.
P2860
Q24626819-CDA533C2-1429-42FD-855B-DD8F21AE9179Q24630458-051C0AEA-659F-4F1B-880E-4DB17FC3652CQ33401642-761E316C-B153-4BE2-9489-E8987C2F6D5AQ33568238-41735FA3-BF97-4919-87E0-010B7709790FQ35849981-8FB2403F-F56A-4D90-BA0E-4E401DC53593Q35858075-A131D773-E409-4748-81DA-6F9F4A64620AQ36056932-ED753340-5DC2-4684-B4DB-E14B07EB36D8Q36494426-834D9E7C-0714-4737-AD6C-DD535DE73183Q36844182-02F4B26F-8C67-46D3-BBC2-F154B396BBDCQ37377304-7FB0FEF4-CC6A-48F4-A898-9F46055B640BQ37799488-A841A9F3-9D9B-4B81-B41D-825A1A747403Q38169806-A9CF6CFB-7365-4C42-B090-2D08046C2E6AQ38467531-13F88D60-91B2-4B51-BBE6-E6580307B517Q38930944-726E8FE0-5624-4316-BB63-59704DF55CF3Q44729890-B5AAF412-EE33-4C87-8EAD-74D23F0254E2Q47805043-0F411042-4FC4-481C-9FD8-905C179E3185Q48029073-08947114-8F76-496C-8B4C-B92C0741C910Q51814416-65036DDD-DE8A-42C9-92D0-A99B57747032Q53633647-AB2AE05E-CE83-4C7F-A4DD-FA9EFBB064BC
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Glucocorticoid-induced osteoporosis.
@ast
Glucocorticoid-induced osteoporosis.
@en
type
label
Glucocorticoid-induced osteoporosis.
@ast
Glucocorticoid-induced osteoporosis.
@en
prefLabel
Glucocorticoid-induced osteoporosis.
@ast
Glucocorticoid-induced osteoporosis.
@en
P1476
Glucocorticoid-induced osteoporosis.
@en
P2093
P356
10.1016/S1043-2760(00)00234-4
P577
2000-04-01T00:00:00Z